1887

Abstract

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death in the world. The incidence of HCC in India is reportedly low and varies from 0.2  to 1.9 %. Aflatoxins, secondary metabolites produced by and , are potent human carcinogens implicated in HCC. The prevalence of aflatoxin B1 (AFB1) as co-carcinogen was analysed using an in-house immunoperoxidase test in 31 liver biopsies and 7 liver-resection specimens from histopathologically proven HCC, and in 15 liver biopsies from cirrhosis patients (control group). Serum was tested for hepatitis B and C serological markers using commercial assays, and for AFB1 using an in-house ELISA with a sensitivity of ∼1 ng ml for AFB1. In spite of positive AFB1 immunostaining in HCC cases, all serum specimens, from both HCC and the control groups, were AFB1-negative. There were 18 (58.1 %) HCC cases that revealed AFB1 in liver biopsies; 68.8 % (=11) of non-B non-C hepatitis cases with HCC and 46.1 % (=6) of the hepatitis B surface-antigen-positive subjects were positive for AFB1. Out of the two hepatitis B/hepatitis C virus co-infected cases, one was positive for AFB1. Of seven tumour-resection samples, six were positive for AFB1. Only one case revealed AFB1 in the non-tumour area of the resected material. Thus AFB1 staining was significantly associated with tumour tissue (=0.03). Aflatoxins proved to have a significant association with HCC in this peninsular part of the subcontinent. The impact seems to be a cumulative process, as revealed by the AFB1 deposits in HCC liver tissue, even though the serum levels were undetectable.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47151-0
2007-11-01
2019-08-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/11/1455.html?itemId=/content/journal/jmm/10.1099/jmm.0.47151-0&mimeType=html&fmt=ahah

References

  1. Block, T. M., Mehta, A. S., Fimmel, C. J. & Jordan, R. ( 2003; ). Molecular viral oncology of hepatocellular carcinoma. Oncogene 22, 5093–5107.[CrossRef]
    [Google Scholar]
  2. Bressac, B., Kew, M., Wands, J. & Ozturk, M. ( 1991; ). Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350, 429–431.[CrossRef]
    [Google Scholar]
  3. Busby, W. F., Jr & Wogan, G. N. ( 1984; ). Aflatoxins. In Chemical Carcinogens, vol. 2, 2nd edn, pp. 945–1136. Edited by C. E. Searle. Washington, DC: American Chemical Society.
  4. Campbell, T. C., Chen, J., Liu, C., Li, J. & Parpia, B. ( 1990; ). Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People's Republic of China. Cancer Res 50, 6882–6893.
    [Google Scholar]
  5. Chen, C. J., Zhang, Y. J., Lu, S. N. & Santell, R. M. ( 1992; ). Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma. Hepatology 16, 1150–1155.[CrossRef]
    [Google Scholar]
  6. De Vries, H. R. & Lamplugh, S. M. ( 1989; ). Aflatoxins in liver biopsies from Kenya. Trop Geogr Med 41, 26–30.
    [Google Scholar]
  7. Dhir, V. & Mohandas, K. M. ( 1998; ). Epidemiology of digestive cancer in India. III. Liver. Indian J Gastroenterol 17, 100–103.
    [Google Scholar]
  8. El-Serag, H. B. ( 2004; ). Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127, S27–S34.[CrossRef]
    [Google Scholar]
  9. Hoseyni, M. S. ( 1992; ). Risk assessment for aflatoxin. III. Modeling the relative risk of hepatocellular cancer. Risk Anal 12, 123–128.[CrossRef]
    [Google Scholar]
  10. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J. & Harris, C. C. ( 1991; ). Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350, 427–428.[CrossRef]
    [Google Scholar]
  11. IARC ( 1993; ). Aflatoxins. IARC Monogr Eval Carcinog Risks Hum 56, 245–395.
    [Google Scholar]
  12. Lam, K. C., Yu, M. C., Leung, J. W. C. & Henderson, B. E. ( 1982; ). Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res 42, 5246–5248.
    [Google Scholar]
  13. Laurent-Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac-Sage, P. & Zucman-Rossi, J. ( 2001; ). Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 120, 1763–1773.[CrossRef]
    [Google Scholar]
  14. Lin, J. K., Mille, J. A. & Miller, E. C. ( 1977; ). 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or ribosomal RNA adducts formed in hepatic microsome-mediated reactions in rat liver in vivo. Cancer Res 37, 4430–4438.
    [Google Scholar]
  15. Lu, S. N., Lin, T. M., Chen, C. J., Chen, J. S., Liaw, Y. F., Chang, W. Y. & Hsu, S. T. ( 1988; ). A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 62, 2051–2055.[CrossRef]
    [Google Scholar]
  16. Marrero, J. A., Fontana, R. J., Fu, S., Conjeevaram, H. S., Su, G. L. & Lok, A. S. ( 2005; ). Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42, 218–224.
    [Google Scholar]
  17. McMahon, G., Davis, E. F., Huber, L. J., Kim, Y. & Wogan, G. N. ( 1990; ). Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors. Proc Natl Acad Sci U S A 87, 1104–1108.[CrossRef]
    [Google Scholar]
  18. Parkin, D. M., Whelan, S. L., Ferlay, J., Raymond, L. & Young, J. ( 1997; ). Cancer Incidence in Five Continents, vol. VII. Lyon: International Agency for Research on Cancer.
  19. Peers, F., Bosch, X., Kaldor, J., Linsell, A. & Pluijmen, M. ( 1987; ). Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer 39, 545–553.[CrossRef]
    [Google Scholar]
  20. Ross, R. K., Yuan, J. M., Yu, M. C., Wogan, G. N., Qian, G. S., Tu, J. T., Groopman, J. D., Gao, Y. T. & Henderson, B. E. ( 1992; ). Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339, 943–946.[CrossRef]
    [Google Scholar]
  21. Shibuya, K., Mathers, C. D., Boschi-Pinto, C., Lopez, A. D. & Murray, C. J. ( 2002; ). Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease. BMC Cancer 2, 37 [CrossRef]
    [Google Scholar]
  22. Tandon, B. N., Krishnamurthy, L., Koshy, A., Tandon, H. D., Ramalingaswami, V., Bhandari, J. R., Mathur, M. M. & Mathur, P. D. ( 1977; ). Study of an epidemic of jaundice, presumably due to toxic hepatitis in Northwest India. Gastroenterology 72, 488–494.
    [Google Scholar]
  23. Van Rensburg, S. J., Cook-Mozaffari, P., Van Schalkwyk, D. J., Van Der Watt, J. J., Vincent, T. J. & Purchase, I. F. ( 1985; ). Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 51, 713–726.[CrossRef]
    [Google Scholar]
  24. Wang, J. S., Huang, T., Su, J., Liang, F., Wei, Z., Liang, Y., Luo, H., Kuang, S.-Y., Qian, G.-S. & other authors ( 2001; ). Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 10, 143–146.
    [Google Scholar]
  25. World Health Organization ( 1998; ). Food additives series 40. In Safety Evaluations of Certain Food Additives and Contaminants. Aflatoxins, pp. 359–468. Geneva: World Health Organization.
  26. Wilkinson, A. P., Denning, D. W. & Morgan, M. R. A. ( 1988; ). Analysis of UK sera for aflatoxin by enzyme-linked immunosorbent assay. Hum Toxicol 7, 353–356.[CrossRef]
    [Google Scholar]
  27. Williams, J. H., Phillips, T. D., Jolly, P. E., Stiles, J. K., Jolly, C. M. & Aggarwal, D. ( 2004; ). Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr 80, 1106–1122.
    [Google Scholar]
  28. Yeh, F. S., Yu, M. C., Mo, C. C., Luo, S., Tong, M. J. & Henderson, B. E. ( 1989; ). B virus, aflatoxins and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 49, 2506–2509.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47151-0
Loading
/content/journal/jmm/10.1099/jmm.0.47151-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error